Phathom Pharmaceuticals Inc (PHAT)
10.31
-0.09
(-0.87%)
USD |
NASDAQ |
Jun 28, 16:00
10.31
0.00 (0.00%)
After-Hours: 20:00
Phathom Pharmaceuticals Accounts Receivable (Quarterly): 3.879M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 3.879M |
December 31, 2023 | 1.637M |
September 30, 2023 |
Date | Value |
---|---|
June 30, 2023 | |
March 31, 2023 | |
December 31, 2022 | 0.00 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2022
3.879M
Maximum
Mar 2024
1.839M
Average
1.637M
Median
Dec 2023
Accounts Receivable (Quarterly) Benchmarks
Insmed Inc | 37.16M |
Regeneron Pharmaceuticals Inc | 5.222B |
Rocket Pharmaceuticals Inc | -- |
Rhythm Pharmaceuticals Inc | 14.70M |
Xeris Biopharma Holdings Inc | 37.41M |